Kozo Yasui

2.5k total citations
70 papers, 1.9k citations indexed

About

Kozo Yasui is a scholar working on Immunology, Molecular Biology and Hematology. According to data from OpenAlex, Kozo Yasui has authored 70 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Immunology, 17 papers in Molecular Biology and 13 papers in Hematology. Recurrent topics in Kozo Yasui's work include Immune Response and Inflammation (17 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (13 papers) and Blood disorders and treatments (9 papers). Kozo Yasui is often cited by papers focused on Immune Response and Inflammation (17 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (13 papers) and Blood disorders and treatments (9 papers). Kozo Yasui collaborates with scholars based in Japan, United States and Nigeria. Kozo Yasui's co-authors include Atsushi Komiyama, Kazunaga Agematsu, A. Baba, Haruo Nagumo, Koji Shinozaki, Sho Hokibara, Takashi Yamazaki, Takayuki Nakazawa, Norimoto Kobayashi and Susumu Ito and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Annals of Internal Medicine.

In The Last Decade

Kozo Yasui

69 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kozo Yasui Japan 25 875 505 327 288 248 70 1.9k
Sanae Ben Mkaddem France 26 931 1.1× 589 1.2× 171 0.5× 235 0.8× 232 0.9× 44 2.1k
Damo Xu United Kingdom 15 966 1.1× 718 1.4× 317 1.0× 131 0.5× 216 0.9× 28 2.1k
Margarita Hurtado-Nédelec France 25 759 0.9× 528 1.0× 278 0.9× 121 0.4× 223 0.9× 42 1.9k
Peter Uciechowski Germany 30 930 1.1× 588 1.2× 175 0.5× 149 0.5× 212 0.9× 48 2.5k
Anton T. J. Tool Netherlands 30 1.5k 1.8× 650 1.3× 460 1.4× 266 0.9× 468 1.9× 67 2.9k
R C Bucknall United Kingdom 25 1.2k 1.3× 604 1.2× 215 0.7× 183 0.6× 165 0.7× 58 2.5k
Stephen Clark United Kingdom 17 1.5k 1.7× 772 1.5× 313 1.0× 312 1.1× 354 1.4× 25 2.7k
Klaus Degitz Germany 31 690 0.8× 586 1.2× 164 0.5× 259 0.9× 498 2.0× 81 3.0k
Jonas Byström United Kingdom 27 805 0.9× 479 0.9× 356 1.1× 178 0.6× 203 0.8× 44 2.0k
Kenneth D. Beaman United States 30 1.4k 1.6× 840 1.7× 99 0.3× 189 0.7× 367 1.5× 121 2.9k

Countries citing papers authored by Kozo Yasui

Since Specialization
Citations

This map shows the geographic impact of Kozo Yasui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kozo Yasui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kozo Yasui more than expected).

Fields of papers citing papers by Kozo Yasui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kozo Yasui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kozo Yasui. The network helps show where Kozo Yasui may publish in the future.

Co-authorship network of co-authors of Kozo Yasui

This figure shows the co-authorship network connecting the top 25 collaborators of Kozo Yasui. A scholar is included among the top collaborators of Kozo Yasui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kozo Yasui. Kozo Yasui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yasui, Kozo. (2014). Immunity against Mycobacterium tuberculosis and the risk of biologic anti-TNF-α reagents. Pediatric Rheumatology. 12(1). 45–45. 30 indexed citations
2.
Kawai, Toshinao, Nobuyuki Watanabe, Katsuhiro Arai, et al.. (2013). Thalidomide attenuates excessive inflammation without interrupting lipopolysaccharide-driven inflammatory cytokine production in chronic granulomatous disease. Clinical Immunology. 147(2). 122–128. 22 indexed citations
3.
Ikeda, Masanori, et al.. (2011). Increased Eosinophilic Cationic Protein in Nasal Fluid in Hospitalized Wheezy Infants with RSV Infection. Allergology International. 60(4). 467–472. 9 indexed citations
4.
Yasui, Kozo, Masato Yashiro, Mitsuru Tsuge, et al.. (2011). Tumor necrosis factor-α can induce Langhans-type multinucleated giant cell formation derived from myeloid dendritic cells. Microbiology and Immunology. 55(11). 809–816. 8 indexed citations
5.
Yasui, Kozo, et al.. (2009). Theophylline inhibits the differentiation of human monocyte into dendritic cell potentially via adenosine receptor antagonism. Clinical & Experimental Allergy. 39(12). 1857–1865. 6 indexed citations
6.
Yamazaki, Takashi, Junya Masumoto, Kazunaga Agematsu, et al.. (2008). Anakinra improves sensory deafness in a Japanese patient with Muckle‐Wells syndrome, possibly by inhibiting the cryopyrin inflammasome. Arthritis & Rheumatism. 58(3). 864–868. 44 indexed citations
7.
Yasui, Kozo & A. Baba. (2006). Therapeutic potential of superoxide dismutase (SOD) for resolution of inflammation. Inflammation Research. 55(9). 359–363. 213 indexed citations
8.
Yasui, Kozo. (2005). Neutrophilic inflammation: pathogenesis and clinical figures. 25(3). 173–176. 2 indexed citations
9.
Yasui, Kozo, Norimoto Kobayashi, Takashi Yamazaki, & Kazunaga Agematsu. (2005). Thalidomide as an Immunotherapeutic Agent: The Effects on Neutrophil- Mediated Inflammation. Current Pharmaceutical Design. 11(3). 395–401. 39 indexed citations
10.
Sekiguchi, Yukari, Kozo Yasui, Toshio Yamazaki, et al.. (2005). Effective Combination Therapy Using Interferon-  and Interleukin-2 for Disseminated Mycobacterium avium Complex Infection in a Pediatric Patient with AIDS. Clinical Infectious Diseases. 41(11). e104–e106. 3 indexed citations
11.
Shiohara, Masaaki, S. Taniguchi, Junya Masumoto, et al.. (2002). ASC, which is composed of a PYD and a CARD, is up-regulated by inflammation and apoptosis in human neutrophils. Biochemical and Biophysical Research Communications. 293(5). 1314–1318. 72 indexed citations
12.
Yamada, Shinji, Kozo Yasui, Koji Shinozaki, Haruo Nagumo, & Toshiko Kumagai. (2002). Detection of neutrophil‐associated immunoglobulin using flow cytometry in autoimmune neutropenia of infancy. Pediatrics International. 44(3). 269–272. 1 indexed citations
13.
Yasui, Kozo & Atsushi Komiyama. (2001). New clinical applications of xanthine derivatives: Modulatory actions on leukocyte survival and function. International Journal of Hematology. 73(1). 87–92. 12 indexed citations
14.
Yasui, Kozo, Bao‐Shan Hu, T Nakazawa, Kazunaga Agematsu, & Atsushi Komiyama. (1997). Theophylline accelerates human granulocyte apoptosis not via phosphodiesterase inhibition.. Journal of Clinical Investigation. 100(7). 1677–1684. 94 indexed citations
15.
Yasui, Kozo, et al.. (1996). Successful Treatment of Behcet Disease with Pentoxifylline. Annals of Internal Medicine. 124(10). 891–893. 66 indexed citations
16.
Yasui, Kozo, et al.. (1996). Effects of high‐dose granulocyte colony‐stimulating factor on neutrophil functions. British Journal of Haematology. 92(3). 571–573. 6 indexed citations
18.
Ishiguro, Akira, Tatsutoshi Nakahata, Toshikazu Shimbo, et al.. (1993). Improvement of neutropenia and neutrophil dysfunction by granulocyte colony-stimulating factor in a patient with glycogen storage disease type Ib. European Journal of Pediatrics. 152(1). 18–20. 17 indexed citations
19.
Yasui, Kozo, Elmer L. Becker, & R.I. Sha’afi. (1992). Lipopolysaccharide and serum cause the translocation of G-protein to the membrane and prime neutrophils via CD14. Biochemical and Biophysical Research Communications. 183(3). 1280–1286. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026